Lifestyle app for MPN patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a digital lifestyle app designed to help people with myeloproliferative neoplasms (MPNs) manage their health and well-being. You would use the app on your phone or computer and share feedback.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a myeloproliferative neoplasm (MPN) like essential thrombocythemia, polycythemia vera, or myelofibrosis.
- You are 18 years old or older.
- You can understand and speak English.
- You are willing to give your consent to join the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
This pilot study tests a lifestyle and movement program for adults with certain myeloproliferative neoplasms (MPNs), aiming to improve well-being through safe exercise habits. You may be considered if you have an MPN and at least one heart-related risk factor.
This study tests a digital application to help patients with acute myeloid leukemia (AML) during their hospital stay. It may assist with tracking symptoms, education, or communication with care teams.
This study asks people with MPN (a type of blood cancer) to share how they feel and to wear a smartwatch-like device. It aims to learn more about your symptoms and daily life to improve care.
This trial tests a digital app designed to help people with multiple myeloma (a blood cancer) manage their quality of life and symptoms. The study wants to see if using this app on a phone or computer can help patients feel better and stay connected to their care.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
Hear when a new Myeloproliferative Neoplasms (MPNs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.